WCM Investment Management LLC lowered its stake in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 2.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 253,678 shares of the medical instruments supplier's stock after selling 5,803 shares during the quarter. WCM Investment Management LLC owned about 1.04% of ICU Medical worth $39,117,000 at the end of the most recent reporting period.
Several other large investors have also recently bought and sold shares of the stock. Jennison Associates LLC bought a new position in shares of ICU Medical during the 4th quarter worth about $556,000. Gagnon Securities LLC increased its stake in ICU Medical by 0.5% during the fourth quarter. Gagnon Securities LLC now owns 28,881 shares of the medical instruments supplier's stock valued at $4,481,000 after acquiring an additional 137 shares during the period. OLD National Bancorp IN increased its stake in ICU Medical by 22.0% during the fourth quarter. OLD National Bancorp IN now owns 1,462 shares of the medical instruments supplier's stock valued at $227,000 after acquiring an additional 264 shares during the period. KBC Group NV raised its holdings in ICU Medical by 2,498.0% in the 4th quarter. KBC Group NV now owns 17,303 shares of the medical instruments supplier's stock valued at $2,685,000 after acquiring an additional 16,637 shares in the last quarter. Finally, Inspire Investing LLC lifted its position in shares of ICU Medical by 13.2% in the 4th quarter. Inspire Investing LLC now owns 2,601 shares of the medical instruments supplier's stock worth $404,000 after acquiring an additional 303 shares during the period. 96.10% of the stock is currently owned by institutional investors and hedge funds.
NASDAQ ICUI opened at $156.65 on Friday. The company has a quick ratio of 1.03, a current ratio of 2.29 and a debt-to-equity ratio of 0.75. ICU Medical, Inc. has a 1-year low of $93.36 and a 1-year high of $196.26. The company has a 50 day moving average of $160.72 and a 200-day moving average of $163.49.
In related news, Director David C. Greenberg sold 972 shares of the business's stock in a transaction that occurred on Wednesday, November 27th. The shares were sold at an average price of $158.11, for a total transaction of $153,682.92. Following the completion of the sale, the director now directly owns 5,037 shares of the company's stock, valued at $796,400.07. The trade was a 16.18 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, COO Christian B. Voigtlander sold 1,962 shares of the stock in a transaction that occurred on Monday, November 25th. The shares were sold at an average price of $169.08, for a total transaction of $331,734.96. The disclosure for this sale can be found here. In the last quarter, insiders have sold 17,737 shares of company stock valued at $2,879,752. 6.70% of the stock is currently owned by corporate insiders.
ICUI has been the subject of a number of recent research reports. Needham & Company LLC restated a "hold" rating on shares of ICU Medical in a research note on Wednesday, November 13th. Jefferies Financial Group raised shares of ICU Medical from a "hold" rating to a "buy" rating and set a $200.00 price objective for the company in a report on Wednesday, December 11th. StockNews.com raised shares of ICU Medical from a "hold" rating to a "buy" rating in a research note on Wednesday, November 20th. Finally, KeyCorp raised their price target on shares of ICU Medical from $198.00 to $209.00 and gave the stock an "overweight" rating in a research note on Wednesday, November 13th. One investment analyst has rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $199.67.
Read Our Latest Stock Analysis on ICUI
ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you make your next trade, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis.
Our team has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and none of the big name stocks were on the list.
They believe these five stocks are the five best companies for investors to buy now...
See The Five Stocks Here
Before you consider ICU Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ICU Medical wasn't on the list.
While ICU Medical currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.